Patents by Inventor Patrice Preville

Patrice Preville has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazopyrimidine nucleoside analogues with anti-HIV activity
    Publication number: 20020061896
    Abstract: The present invention accordingly provides imidazopyrimidine nucleoside compounds of formula (I) 1
    Type: Application
    Filed: December 28, 2000
    Publication date: May 23, 2002
    Inventors: Arshad Siddiqul, Alex Cimpoia, Patrice Preville
  • Thiophene integrin inhibitors
    Patent number: 6274620
    Abstract: The present invention comprises compounds that are effective inhibitors of integrins, particularly &agr;v&bgr;3 and &agr;v&bgr;5 integrins. Particularly, the compounds are of formula I and pharmaceutically acceptable salts thereof wherein X,Y1 W, R1 to R5, A and B are defined according to the disclosure herein.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: August 14, 2001
    Assignee: BioChem Pharma Inc.
    Inventors: Denis Labrecque, Giorgio Attardo, Monica Bubenik, Laval Chan, Sylvie Charron, Réal Denis, Guy Falardeau, Serge Lamothe, Patrice Préville, Boulos Zacharie
  • Low molecular weight bicyclic thrombin inhibitors
    Patent number: 6057314
    Abstract: This invention relates to the discovery of heterocyclic competitive inhibitors of the enzyme thrombin, their preparation, and pharmaceutical compositions thereof. As well, this invention relates to the use of such compounds and compositions in vitro as anticoagulants and in vivo as agents for the treatment and prophylaxis of thrombotic disorders such as venous thrombosis, pulmonary embolism and arterial thrombosis resulting in acute ischemic events such as myocardial infarction or cerebral infarction. Moreover, these compounds and compositions have therapeutic utility for the prevention and treatment of coagulopathies associated with coronary bypass operations as well as restenotic events following transluminal angioplasty.
    Type: Grant
    Filed: June 23, 1997
    Date of Patent: May 2, 2000
    Assignee: Biochem Pharma Inc.
    Inventors: John Dimaio, M. Arshad Siddiqui, John W. Gillard, Yves St-Denis, Micheline Tarazi, Patrice Preville, Sophie Levesque, Benoit Bachand, Annette Marian Doherty, Jeremy John Edmunds